{"id":"W4379522838","doi":"10.1136/annrheumdis-2023-eular.1423","title":"POS0057 WHICH ADVANCED TREATMENT SHOULD BE USED FOLLOWING THE FAILURE OF A FIRST-LINE ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS? 15 YEARS OF EVIDENCE FROM THE QUEBEC REGISTRY RHUMADATA™","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Osteoporosis Canada","funders":"Sanofi Genzyme; Ultragenyx Pharmaceutical; Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Antirheumatic Agents; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007938618,0.0004660213,0.001394467,0.001005755,0.001083566,0.002210366,0.001488675,0.001875766,0.01096092],"category_scores_gemma":[0.04135349,0.0003335979,0.002657728,0.003474261,0.0008939331,0.001200922,0.0005365709,0.001713095,0.0009427615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01572136,"about_ca_system_score_gemma":0.03092537,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8580352,"about_ca_topic_score_gemma":0.9195854,"domain_scores_codex":[0.9938783,0.002591624,0.0008101862,0.0006109489,0.001446643,0.0006624031],"domain_scores_gemma":[0.9402152,0.01882414,0.0187162,0.001686057,0.01715606,0.003402263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03035939,0.0003250728,0.6182749,0.01034122,0.01025493,0.0002437629,0.0004100216,0.001081836,0.0003382565,0.001943593,0.08499815,0.2414288],"study_design_scores_gemma":[0.01006011,0.001698295,0.8634911,0.02317741,0.01564212,0.0002359736,0.0009956147,0.001560668,0.0002733011,0.0007209259,0.08194526,0.0001992953],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.289094,0.5046931,0.001261458,0.04595502,0.003587,0.0007555952,0.09515999,0.0001153181,0.0593786],"genre_scores_gemma":[0.8689849,0.08826548,0.001804743,0.01115155,0.001726516,0.0002967672,0.02226413,0.00004322925,0.005462667],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1419648,"threshold_uncertainty_score":0.2856017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06821244600624869,"score_gpt":0.3250485492963329,"score_spread":0.2568361032900842,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}